Gilead Sciences, Inc. (GILD)
151.21
+1.60
(+1.07%)
USD |
NASDAQ |
Sep 03, 16:00
149.81
-1.40
(-0.93%)
After-Hours: 20:00
Gilead Sciences Cash from Operations (Annual) : 10.02B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 10.02B |
| December 31, 2024 | 10.83B |
| December 31, 2023 | 8.006B |
| December 31, 2022 | 9.072B |
| December 31, 2021 | 11.38B |
| December 31, 2020 | 8.168B |
| December 31, 2019 | 9.144B |
| December 31, 2018 | 8.40B |
| December 31, 2017 | 11.90B |
| December 31, 2016 | 17.05B |
| December 31, 2015 | 20.33B |
| December 31, 2014 | 12.82B |
| December 31, 2013 | 3.105B |
| December 31, 2012 | 3.195B |
| December 31, 2011 | 3.639B |
| December 31, 2010 | 2.834B |
| December 31, 2009 | 3.080B |
| December 31, 2008 | 2.205B |
| Date | Value |
|---|---|
| December 31, 2007 | 1.765B |
| December 31, 2006 | 1.218B |
| December 31, 2005 | 715.08M |
| December 31, 2004 | 511.38M |
| December 31, 2003 | 234.61M |
| December 31, 2002 | 74.41M |
| December 31, 2001 | -88.13M |
| December 31, 2000 | -38.20M |
| December 31, 1999 | -62.55M |
| December 31, 1998 | -46.72M |
| December 31, 1997 | -19.86M |
| December 31, 1996 | -16.46M |
| December 31, 1995 | -23.05M |
| March 31, 1995 | |
| March 31, 1994 | -22.40M |
| March 31, 1993 | -8.896M |
| March 31, 1992 | -3.708M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.631B |
| AbbVie, Inc. | 19.03B |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| Amgen, Inc. | 9.958B |
| Biogen, Inc. | 2.205B |